4Sc AG logo

VSC - 4Sc AG News Story

€1.4 -0.3  -18.4%

Last Trade - 07/05/21

Sector
Healthcare
Size
Small Cap
Market Cap £61.4m
Enterprise Value £31.3m
Revenue £1.96m
Position in Universe 794th / 1050

BRIEF-4Sc And Maruho To Terminate Development Agreement Related To 4Sc's Kv1.3 Inhibitors

Fri 11th September, 2020 6:32am
Sept 11 (Reuters) - 4SC AG  VSCk.DE :
    * MARUHO AND 4SC AGREE TO TERMINATE THEIR DEVELOPMENT
AGREEMENT
RELATED TO 4SC'S KV1.3 INHIBITORS
    * 4SC TO REACQUIRE ALL RIGHTS TO DEVELOPMENT PROGRAM
    * DEVELOPMENT OF 4SC'S KV1.3 INHIBITORS. AS A CONSEQUENCE OF
THIS
DECISION EXCLUSIVE LICENSE AGREEMENT DATED JULY 15, 2017 IS
TERMINATED
    * ALL RIGHTS LICENSED TO MARUHO AND ALL DATA AND MATERIAL
GENERATED DURING COLLABORATION WILL BE RETURNED TO 4SC AND 4SC
WILL BE FREE TO PURSUE ALL FURTHER DEVELOPMENT OPPORTUNITIES FOR
THIS CLASS OF COMPOUNDS

Source text for Eikon:  ID:nPexV0dQma 
Further company coverage:  VSCk.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.